Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-01 @ 3:55 PM
Study NCT ID:
NCT01274351
Status:
COMPLETED
Last Update Posted:
2020-09-01
First Post:
2011-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Nilotinib as First Line Treatment in Philadelphia Chromosome Positive(Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Sponsor:
Organization: